Page 381 - Clinical Immunology_ Principles and Practice ( PDFDrive )

CHaPtEr 24 Eosinophils and Eosinophilia 361

8. Melo RCN, Perez SAC, Spencer LA, et al. Intragranular vesiculotubular 23. Wu D, Molofsky AB, Liang HE, et al. Eosinophils sustain adipose
compartments are involved in piecemeal degranulation by activated alternatively activated macrophages associated with glucose homeostasis.
human eosinophils. Traffic 2005;6:866–79. Science 2011;332:243–7.
9. Hogan SP, Rosenberg HF, Moqbel R, et al. Eosinophils: biological 24. Wilson ME, Weller PF. Eosinophilia. In: Guerrant RL, Walker DH, Weller
properties and role in health and disease. Clin Exp Allergy PF, editors. Tropical infectious diseases: principles, pathogens and
2008;38:709–50. practice. 3rd ed. Philadelphia, Penn.: Elsevier; 2011. p. 939–49.
10. Spencer LA, Szela CT, Perez SA, et al. Human eosinophils constitutively 25. Klion AD, Bochner BS, Gleich GJ, et al. Approaches to the treatment of
express multiple Th1, Th2, and immunoregulatory cytokines that are hypereosinophilic syndromes: a workshop summary report. J Allergy Clin
secreted rapidly and differentially. J Leukoc Biol 2009;85:117–23. Immunol 2006;117:1292–302.
11. Melo RC, Weller PF. Piecemeal degranulation in human eosinophils: a 26. Ogbogu PU, Bochner BS, Butterfield JH, et al. Hypereosinophilic
distinct secretion mechanism underlying inflammatory responses. Histol syndrome: a multicenter, retrospective analysis of clinical characteristics
Histopathol 2010;25:1341–54. and response to therapy. J Allergy Clin Immunol 2009;124:1319–25.
12. Spencer LA, Melo RCN, Perez SAC, et al. Cytokine receptor-mediated 27. Valent P, Gleich GJ, Reiter A, et al. Pathogenesis and classification of
trafficking of preformed IL-4 in eosinophils identifies an innate immune eosinophil disorders: a review of recent developments in the field. Expert
mechanism of cytokine secretion. Proc Natl Acad Sci USA Rev Hematol 2012;5:157–76.
2006;103:3333–8. 28. Khoury P, Desmond R, Pabon A, et al. Clinical features predict
13. Neves JS, Perez SA, Spencer LA, et al. Eosinophil granules function responsiveness to imatinib in platelet derived growth factor receptor
extracellularly as receptor-mediated secretory organelles. Proc Natl Acad alpha-negative hypereosinophilic syndrome. Allergy 2016;71:803–10.
Sci USA 2008;105:18478–83. 29. Lefevre G, Copin MC, Staumont-Salle D, et al. The lymphoid variant of
14. Neves JS, Weller PF. Functional extracellular eosinophil granules: novel hypereosinophilic syndrome: study of 21 patients with CD3-CD4+
implications in eosinophil immunobiology. Curr Opin Immunol aberrant T-cell phenotype. Medicine (Baltimore) 2014;93:255–66.
2009;21:694–9. 30. Chen YY, Khoury P, Ware JM, et al. Marked and persistent eosinophilia in
15. Ueki S, Melo RC, Ghiran I, et al. Eosinophil extracellular DNA trap cell the absence of clinical manifestations. J Allergy Clin Immunol
death mediates lytic release of free secretion-competent eosinophil 2014;133:1195–202.
granules in humans. Blood 2013;121:2074–83. 31. Rothenberg ME, Klion AD, Roufosse FE, et al. Treatment of patients with
16. Klion AD, Nutman TB. The role of eosinophils in host defense against the hypereosinophilic syndrome with mepolizumab. N Engl J Med
helminth parasites. J Allergy Clin Immunol 2004;113:30–7. 2008;358:1215–28.
17. Swartz JM, Dyer KD, Cheever AW, et al. Schistosoma mansoni infection in 32. Akuthota P, Weller PF. Eosinophilic pneumonias. Clin Microbiol Rev
eosinophil lineage-ablated mice. Blood 2006;108:2420–7. 2012;25:649–60.
18. Padigel UM, Hess JA, Lee JJ, et al. Eosinophils act as antigen presenting 33. Comarmond C, Pagnoux C, Khellaf M, et al. Eosinophilic granulomatosis
cells to induce immunity to Strongyloides stercoralis in mice. J Infect Dis with polyangiitis (Churg-Strauss): clinical characteristics and long-term
2007;196:1844–51. follow-up of the 383 patients enrolled in the French Vasculitis Study
19. Fabre V, Beiting DP, Bliss SK, et al. Eosinophil deficiency compromises Group cohort. Arthritis Rheum 2013;65:270–81.
parasite survival in chronic nematode infection. J Immunol 34. Long H, Zhang G, Wang L, et al. Eosinophilic skin diseases: a
2009;182:1577–83. comprehensive review. Clin Rev Allergy Immunol 2016;50:189–213.
20. Akuthota P, Wang HB, Spencer LA, et al. Immunoregulatory roles of 35. Ben m’rad M, Leclerc-Mercier S, Blanche P, et al. Drug-induced
eosinophils: a new look at a familiar cell. Clin Exp Allergy hypersensitivity syndrome: clinical and biologic disease patterns in 24
2008;38:1254–63. patients. Medicine (Baltimore) 2009;88:131–40.
21. Wang HB, Ghiran I, Matthaei K, et al. Airway eosinophils: allergic 36. Williams KW, Milner JD, Freeman AF. Eosinophilia associated with
inflammation recruited professional antigen-presenting cells. J Immunol disorders of immune deficiency or immune dysregulation. Immunol
2007;179:7585–92. Allergy Clin North Am 2015;35:523–44.
22. Chu VT, Frohlich A, Steinhauser G, et al. Eosinophils are required for the 37. Klion A. Hypereosinophilic syndrome: current approach to diagnosis and
maintenance of plasma cells in the bone marrow. Nat Immunol treatment. Annu Rev Med 2009;60:293–306.
2011;12:151–9.